Pro Medicus Secures $40M Deal with LucidHealth to Expand Imaging Solutions

2 min read | March 03, 2025 01:44 PM AEDT | By Team Kalkine Media

Google News:

Pro Medicus Secures $40M Deal with LucidHealth to Expand Imaging Solutions — Image source: shutterstock

Recent News

Zip Shares Push Higher as Market Watches Key Turning Point

Could These Under-the-Radar ASX Stocks Be Worth Watching?

ASX 200 Soars as Trump Signals Surprise Iran Peace Shift

Which ASX Small Caps Are Making Early Moves Today?

Make Kalkine Media
My Trusted Source

Highlights

Pro Medicus (ASX:PME) signs a $40 million, seven-year contract with LucidHealth.

The agreement will deploy the Visage 7 enterprise imaging platform across 140 care sites.

A phased rollout is set to begin in the third and fourth quarters of this year.

Pro Medicus (ASX:PME) has strengthened its footprint in the U.S. healthcare sector with a significant $40 million agreement. The Australian-based health imaging technology provider has entered into a seven-year contract with LucidHealth, a U.S. radiology services network that operates across 140 care sites. This partnership will see the deployment of Pro Medicus’ advanced Visage 7 enterprise imaging platform throughout LucidHealth’s facilities.

The deal was secured through Pro Medicus' wholly owned U.S. subsidiary, Visage Imaging, and is expected to enhance efficiency in medical imaging across LucidHealth’s network. The rollout of the Visage 7 system is set to begin immediately, with the phased implementation expected to commence late in the third quarter and continue into the fourth quarter of the year.

Expanding Medical Imaging Capabilities

This latest contract highlights the growing demand for cutting-edge imaging solutions in the healthcare industry. Visage 7, Pro Medicus' flagship product, is known for its speed and scalability, making it a preferred choice for hospitals, imaging centers, and healthcare providers worldwide. The platform offers a cloud-based, enterprise-grade solution designed for both public and private cloud environments, enabling seamless integration with existing healthcare systems.

Since acquiring Visage Imaging in 2009, Pro Medicus (ASX:PME) has focused on expanding its presence in international markets. The company’s emphasis on innovation and cloud-based solutions has contributed to its increasing adoption by healthcare providers looking to modernize their imaging infrastructure.

Strategic Growth in the U.S. Market

The agreement with LucidHealth aligns with Pro Medicus’ long-term strategy of expanding its footprint in the U.S. radiology market. The demand for efficient, high-quality imaging solutions continues to rise, and cloud-based platforms like Visage 7 are playing a pivotal role in modernizing medical imaging workflows.

With a structured implementation plan in place, the collaboration between Pro Medicus and LucidHealth is set to improve imaging efficiency, reduce turnaround times, and enhance patient care. As the phased rollout begins, this partnership marks another milestone in Pro Medicus’ growing influence in the global healthcare technology landscape.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.